US9183852048 - Common Stock
VTV THERAPEUTICS INC- CL A
NASDAQ:VTVT (5/2/2024, 7:26:34 PM)
23.6999
-4.26 (-15.24%)
vTv Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in High Point, North Carolina and currently employs 13 full-time employees. The company went IPO on 2015-07-30. vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for diabetes. Its products pipeline includes TTP399, TTP273, HPP737 and HPP593. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. Its HPP737 is an orally administered, non-central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. TTP273 is an orally available, small molecule glucagon-like peptide 1 (GLP-1) receptor agonist, which is focused on treating postprandial hyperglycemia in cystic fibrosis related diabetes (CFRD) patients and cystic fibrosis patients. Its products pipeline also includes HPP593, Nrf2/Bach1 Modulator Program, Azeliragon and HPP3033.
VTV THERAPEUTICS INC- CL A
3980 Premier Dr, Suite 310
High Point NORTH CAROLINA 27265
P: 13368410300
CEO: Stephen L. Holcombe
Employees: 13
Website: https://vtvtherapeutics.com/
/PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Recently completed $51 million PIPE from healthcare-focused institutional investors and the JDRF T1D Fund.Company's first Phase 3 clinical trial of...
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare stocks have started the year off very strongly, propelled by excitem...
HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the...
The company reported in-line sales for the fourth quarter, but shares soared by double digits.
Here you can normally see the latest stock twits on VTVT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: